Global Anti-HER2 Therapy Market Research Report 2024(Status and Outlook)
Report Overview:
Anti-HER2 Therapy is a class of medicines used to treat all stages of HER2-positive breast cancer and certain HER2-low breast cancers.In HER2-positive breast cancer, the HER2 (human epidermal growth factor receptor 2) gene doesn’t work correctly and makes too many copies of itself. These extra HER2 genes make too many proteins known as HER2 receptors.Anti-HER2 medicines attach to the HER2 receptor proteins on the surface of breast cancer cells.Anti-HER2 medicines work by blocking the HER2 receptors from receiving the growth signals in HER2-positive breast cancer. By blocking the growth signals, anti-HER2 medicines can slow or stop the growth of HER2-positive and HER2-low breast cancer. Anti-HER2 medicines only work on HER2-positive and HER2-low breast cancer. They do not work on HER2-negative breast cancer.
The Global Anti-HER2 Therapy Market Size was estimated at USD 5932.45 million in 2023 and is projected to reach USD 7725.59 million by 2029, exhibiting a CAGR of 4.50% during the forecast period.
This report provides a deep insight into the global Anti-HER2 Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-HER2 Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-HER2 Therapy market in any manner.
Global Anti-HER2 Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
Bayer
Abbott
AbbVie
Pfizer
Sanofi
Merck
Glenmark Pharmaceuticals
Roche
Novartis
Astra Zeneca
Daiichi Sankyo
Celltrion
Teva
Biocon
Viatris
Market Segmentation (by Type)
Anti-HER2 Monoclonal Antibodies
Antibody-Drug Conjugate
Kinase Inhibitors
Market Segmentation (by Application)
Online Pharmacy
Retail Pharmacy
Medical Clinics
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Anti-HER2 Therapy Market
- Overview of the regional outlook of the Anti-HER2 Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-HER2 Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Anti-HER2 Therapy
- 1.2 Key Market Segments
- 1.2.1 Anti-HER2 Therapy Segment by Type
- 1.2.2 Anti-HER2 Therapy Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Anti-HER2 Therapy Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Anti-HER2 Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
- 2.1.2 Global Anti-HER2 Therapy Sales Estimates and Forecasts (2019-2030)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Anti-HER2 Therapy Market Competitive Landscape
- 3.1 Global Anti-HER2 Therapy Sales by Manufacturers (2019-2024)
- 3.2 Global Anti-HER2 Therapy Revenue Market Share by Manufacturers (2019-2024)
- 3.3 Anti-HER2 Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.4 Global Anti-HER2 Therapy Average Price by Manufacturers (2019-2024)
- 3.5 Manufacturers Anti-HER2 Therapy Sales Sites, Area Served, Product Type
- 3.6 Anti-HER2 Therapy Market Competitive Situation and Trends
- 3.6.1 Anti-HER2 Therapy Market Concentration Rate
- 3.6.2 Global 5 and 10 Largest Anti-HER2 Therapy Players Market Share by Revenue
- 3.6.3 Mergers & Acquisitions, Expansion
- 4 Anti-HER2 Therapy Industry Chain Analysis
- 4.1 Anti-HER2 Therapy Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Anti-HER2 Therapy Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Market Restraints
- 5.5 Industry News
- 5.5.1 New Product Developments
- 5.5.2 Mergers & Acquisitions
- 5.5.3 Expansions
- 5.5.4 Collaboration/Supply Contracts
- 5.6 Industry Policies
- 6 Anti-HER2 Therapy Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Anti-HER2 Therapy Sales Market Share by Type (2019-2024)
- 6.3 Global Anti-HER2 Therapy Market Size Market Share by Type (2019-2024)
- 6.4 Global Anti-HER2 Therapy Price by Type (2019-2024)
- 7 Anti-HER2 Therapy Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Anti-HER2 Therapy Market Sales by Application (2019-2024)
- 7.3 Global Anti-HER2 Therapy Market Size (M USD) by Application (2019-2024)
- 7.4 Global Anti-HER2 Therapy Sales Growth Rate by Application (2019-2024)
- 8 Anti-HER2 Therapy Market Segmentation by Region
- 8.1 Global Anti-HER2 Therapy Sales by Region
- 8.1.1 Global Anti-HER2 Therapy Sales by Region
- 8.1.2 Global Anti-HER2 Therapy Sales Market Share by Region
- 8.2 North America
- 8.2.1 North America Anti-HER2 Therapy Sales by Country
- 8.2.2 U.S.
- 8.2.3 Canada
- 8.2.4 Mexico
- 8.3 Europe
- 8.3.1 Europe Anti-HER2 Therapy Sales by Country
- 8.3.2 Germany
- 8.3.3 France
- 8.3.4 U.K.
- 8.3.5 Italy
- 8.3.6 Russia
- 8.4 Asia Pacific
- 8.4.1 Asia Pacific Anti-HER2 Therapy Sales by Region
- 8.4.2 China
- 8.4.3 Japan
- 8.4.4 South Korea
- 8.4.5 India
- 8.4.6 Southeast Asia
- 8.5 South America
- 8.5.1 South America Anti-HER2 Therapy Sales by Country
- 8.5.2 Brazil
- 8.5.3 Argentina
- 8.5.4 Columbia
- 8.6 Middle East and Africa
- 8.6.1 Middle East and Africa Anti-HER2 Therapy Sales by Region
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Egypt
- 8.6.5 Nigeria
- 8.6.6 South Africa
- 9 Key Companies Profile
- 9.1 GlaxoSmithKline
- 9.1.1 GlaxoSmithKline Anti-HER2 Therapy Basic Information
- 9.1.2 GlaxoSmithKline Anti-HER2 Therapy Product Overview
- 9.1.3 GlaxoSmithKline Anti-HER2 Therapy Product Market Performance
- 9.1.4 GlaxoSmithKline Business Overview
- 9.1.5 GlaxoSmithKline Anti-HER2 Therapy SWOT Analysis
- 9.1.6 GlaxoSmithKline Recent Developments
- 9.2 Bayer
- 9.2.1 Bayer Anti-HER2 Therapy Basic Information
- 9.2.2 Bayer Anti-HER2 Therapy Product Overview
- 9.2.3 Bayer Anti-HER2 Therapy Product Market Performance
- 9.2.4 Bayer Business Overview
- 9.2.5 Bayer Anti-HER2 Therapy SWOT Analysis
- 9.2.6 Bayer Recent Developments
- 9.3 Abbott
- 9.3.1 Abbott Anti-HER2 Therapy Basic Information
- 9.3.2 Abbott Anti-HER2 Therapy Product Overview
- 9.3.3 Abbott Anti-HER2 Therapy Product Market Performance
- 9.3.4 Abbott Anti-HER2 Therapy SWOT Analysis
- 9.3.5 Abbott Business Overview
- 9.3.6 Abbott Recent Developments
- 9.4 AbbVie
- 9.4.1 AbbVie Anti-HER2 Therapy Basic Information
- 9.4.2 AbbVie Anti-HER2 Therapy Product Overview
- 9.4.3 AbbVie Anti-HER2 Therapy Product Market Performance
- 9.4.4 AbbVie Business Overview
- 9.4.5 AbbVie Recent Developments
- 9.5 Pfizer
- 9.5.1 Pfizer Anti-HER2 Therapy Basic Information
- 9.5.2 Pfizer Anti-HER2 Therapy Product Overview
- 9.5.3 Pfizer Anti-HER2 Therapy Product Market Performance
- 9.5.4 Pfizer Business Overview
- 9.5.5 Pfizer Recent Developments
- 9.6 Sanofi
- 9.6.1 Sanofi Anti-HER2 Therapy Basic Information
- 9.6.2 Sanofi Anti-HER2 Therapy Product Overview
- 9.6.3 Sanofi Anti-HER2 Therapy Product Market Performance
- 9.6.4 Sanofi Business Overview
- 9.6.5 Sanofi Recent Developments
- 9.7 Merck
- 9.7.1 Merck Anti-HER2 Therapy Basic Information
- 9.7.2 Merck Anti-HER2 Therapy Product Overview
- 9.7.3 Merck Anti-HER2 Therapy Product Market Performance
- 9.7.4 Merck Business Overview
- 9.7.5 Merck Recent Developments
- 9.8 Glenmark Pharmaceuticals
- 9.8.1 Glenmark Pharmaceuticals Anti-HER2 Therapy Basic Information
- 9.8.2 Glenmark Pharmaceuticals Anti-HER2 Therapy Product Overview
- 9.8.3 Glenmark Pharmaceuticals Anti-HER2 Therapy Product Market Performance
- 9.8.4 Glenmark Pharmaceuticals Business Overview
- 9.8.5 Glenmark Pharmaceuticals Recent Developments
- 9.9 Roche
- 9.9.1 Roche Anti-HER2 Therapy Basic Information
- 9.9.2 Roche Anti-HER2 Therapy Product Overview
- 9.9.3 Roche Anti-HER2 Therapy Product Market Performance
- 9.9.4 Roche Business Overview
- 9.9.5 Roche Recent Developments
- 9.10 Novartis
- 9.10.1 Novartis Anti-HER2 Therapy Basic Information
- 9.10.2 Novartis Anti-HER2 Therapy Product Overview
- 9.10.3 Novartis Anti-HER2 Therapy Product Market Performance
- 9.10.4 Novartis Business Overview
- 9.10.5 Novartis Recent Developments
- 9.11 Astra Zeneca
- 9.11.1 Astra Zeneca Anti-HER2 Therapy Basic Information
- 9.11.2 Astra Zeneca Anti-HER2 Therapy Product Overview
- 9.11.3 Astra Zeneca Anti-HER2 Therapy Product Market Performance
- 9.11.4 Astra Zeneca Business Overview
- 9.11.5 Astra Zeneca Recent Developments
- 9.12 Daiichi Sankyo
- 9.12.1 Daiichi Sankyo Anti-HER2 Therapy Basic Information
- 9.12.2 Daiichi Sankyo Anti-HER2 Therapy Product Overview
- 9.12.3 Daiichi Sankyo Anti-HER2 Therapy Product Market Performance
- 9.12.4 Daiichi Sankyo Business Overview
- 9.12.5 Daiichi Sankyo Recent Developments
- 9.13 Celltrion
- 9.13.1 Celltrion Anti-HER2 Therapy Basic Information
- 9.13.2 Celltrion Anti-HER2 Therapy Product Overview
- 9.13.3 Celltrion Anti-HER2 Therapy Product Market Performance
- 9.13.4 Celltrion Business Overview
- 9.13.5 Celltrion Recent Developments
- 9.14 Teva
- 9.14.1 Teva Anti-HER2 Therapy Basic Information
- 9.14.2 Teva Anti-HER2 Therapy Product Overview
- 9.14.3 Teva Anti-HER2 Therapy Product Market Performance
- 9.14.4 Teva Business Overview
- 9.14.5 Teva Recent Developments
- 9.15 Biocon
- 9.15.1 Biocon Anti-HER2 Therapy Basic Information
- 9.15.2 Biocon Anti-HER2 Therapy Product Overview
- 9.15.3 Biocon Anti-HER2 Therapy Product Market Performance
- 9.15.4 Biocon Business Overview
- 9.15.5 Biocon Recent Developments
- 9.16 Viatris
- 9.16.1 Viatris Anti-HER2 Therapy Basic Information
- 9.16.2 Viatris Anti-HER2 Therapy Product Overview
- 9.16.3 Viatris Anti-HER2 Therapy Product Market Performance
- 9.16.4 Viatris Business Overview
- 9.16.5 Viatris Recent Developments
- 10 Anti-HER2 Therapy Market Forecast by Region
- 10.1 Global Anti-HER2 Therapy Market Size Forecast
- 10.2 Global Anti-HER2 Therapy Market Forecast by Region
- 10.2.1 North America Market Size Forecast by Country
- 10.2.2 Europe Anti-HER2 Therapy Market Size Forecast by Country
- 10.2.3 Asia Pacific Anti-HER2 Therapy Market Size Forecast by Region
- 10.2.4 South America Anti-HER2 Therapy Market Size Forecast by Country
- 10.2.5 Middle East and Africa Forecasted Consumption of Anti-HER2 Therapy by Country
- 11 Forecast Market by Type and by Application (2025-2030)
- 11.1 Global Anti-HER2 Therapy Market Forecast by Type (2025-2030)
- 11.1.1 Global Forecasted Sales of Anti-HER2 Therapy by Type (2025-2030)
- 11.1.2 Global Anti-HER2 Therapy Market Size Forecast by Type (2025-2030)
- 11.1.3 Global Forecasted Price of Anti-HER2 Therapy by Type (2025-2030)
- 11.2 Global Anti-HER2 Therapy Market Forecast by Application (2025-2030)
- 11.2.1 Global Anti-HER2 Therapy Sales (K Units) Forecast by Application
- 11.2.2 Global Anti-HER2 Therapy Market Size (M USD) Forecast by Application (2025-2030)
- 12 Conclusion and Key Findings
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook